Official websites use .gov
A
.gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
To apply to an open position, click the link and follow the instructions included for that position. You may also send an email to contact@isotopes.gov with the position title, location and attached cover letter and resume. Once received, our staff will assist you in applying for the position.
The Isotope Program (IP) in the Inorganic Isotope & Actinide Chemistry group (C-IIAC) produces and purifies radionuclides for medical and industrial applications as well as for fundamental research. We are looking for an experienced shipper to join the team and direct all aspects of logistics with respect to shipping and transporting materials at our production (Isotope Production Facility – IPF) and processing sites (Hot Cells wing). Our shipping team facilitates the transfer of highly active targets among accelerator, radiological and nuclear facilities on campus as well as off-site laboratories, ships our isotope products to customers all over the world, and the receipt of materials from external laboratories to our facilities for processing and R&D activities. These materials are used for cutting edge medical treatments, imaging for cancer and heart disease, industrial uses such as oil and gas exploration, and in national security and government applications.
The Radionuclide Production and Molecular Radiotherapy Research Laboratories in the Department of Radiation Oncology at the University of Washington (Seattle, WA) is seeking candidates for a full time Postdoctoral Scholar research position in radionuclide production for molecular radiotherapy. Our research group develops and evaluates radiochemistry methods that can be applied to produce and purify therapeutic and theranostic radionuclides, as well as development of radiolabeling reagents/chelators used for attaching radionuclides to biological targeting molecules, such as monoclonal antibodies (MAbs) for cancer therapy. Preclinical research in astatine-211-labeled MAbs conducted by our group has been translated to the clinic and is presently being evaluated in multiple human trials. This position will assist in developing new cancer therapies, commit to laboratory safety, and work independently. The incumbent will learn about radiochemical methods and work with radionuclides in the development of production methods and new radiopharmaceuticals. Our research is a team effort, and the candidate will be required to participate in a number of aspects of the research as desired and needed.
